Lupus Autoantibodies
ANA (>95% sensitive screening); Anti-dsDNA (specific, fluctuates with disease activity and lupus nephritis); Anti-Smith (most specific, static titers).
Rheumatoid Arthritis
Symmetric polyarthritis of MCP, PIP, and carpal joints (spares DIPs); morning stiffness >60 min; Anti-CCP (highest specificity >95%, predicts erosions).
Gout Crystals
Monosodium urate; needle-shaped, strongly negatively birefringent (yellow parallel, blue perpendicular); acute Rx: NSAIDs (indomethacin), colchicine, or steroids.
Pseudogout (CPPD)
Calcium pyrophosphate dihydrate; rhomboid-shaped, weakly positively birefringent (blue parallel); knee chondrocalcinosis; linked to hemochromatosis and hyperparathyroidism.
Drug-Induced Lupus
Triggered by hydralazine, procainamide, isoniazid, minocycline, or anti-TNF agents; anti-histone antibodies in >95%; spares kidneys and CNS.
Systemic Sclerosis Subtypes
Diffuse (anti-Scl-70/topoisomerase I, rapid skin thickening, ILD, scleroderma renal crisis) vs. Limited/CREST (anti-centromere, late pulmonary arterial hypertension).
Inflammatory Myopathies
Dermatomyositis (perimysial CD4+ infiltrate, Gottron papules, heliotrope rash, anti-Mi-2, occult malignancy) vs. Polymyositis (endomysial CD8+ T-cell invasion).
Septic Arthritis Threshold
Synovial WBC >50,000/mm3 (>90% PMNs); S. aureus most common overall, N. gonorrhoeae in young sexually active adults; requires emergent arthrocentesis and drainage.
Comprehensive Rheumatology Autoantibody Master Table
Systemic autoimmune rheumatic diseases are diagnosed by pairing a sensitive screening assay—most commonly Indirect Immunofluorescence Antinuclear Antibody (ANA)—with highly specific extractable nuclear antigen (ENA) and cytoplasmic autoantibody sub-serologies. Understanding the precise molecular target of each autoantibody predicts both the clinical phenotype (such as diffuse vs. limited systemic sclerosis or lupus nephritis) and organ-specific surveillance requirements.
| Antibody | Associated Disease | Clinical & Board Significance |
|---|---|---|
| Anti-dsDNA | Systemic Lupus Erythematosus (SLE) | High specificity; titers fluctuate with disease activity and renal involvement (Lupus Nephritis) |
| Anti-Smith (Sm) | Systemic Lupus Erythematosus (SLE) | Most specific antibody for SLE; does not correlate with disease activity |
| Anti-Histone | Drug-Induced Lupus (DILE) | Positive in > 95% of DILE (Hydralazine, Procainamide, Isoniazid, Minocycline) |
| Anti-CCP (ACPA) | Rheumatoid Arthritis | Highest specificity (> 95%); predicts aggressive, erosive disease course |
| Anti-Ro (SSA) / Anti-La (SSB) | Sjögren Syndrome & Neonatal Lupus | Risk of Congenital Complete Heart Block in neonates born to SSA+ mothers |
| Anti-Centromere | Limited Cutaneous Systemic Sclerosis (CREST) | Calcinosis, Raynaud, Esophageal dysmotility, Sclerodactyly, Telangiectasia |
| Anti-Scl-70 (Topoisomerase I) | Diffuse Cutaneous Systemic Sclerosis | Extensive skin thickening, high risk of Pulmonary Interstitial Fibrosis and Renal Crisis |
| Anti-Jo-1 (Histidyl-tRNA synthetase) | Polymyositis / Dermatomyositis | Associated with interstitial lung disease and 'mechanic's hands' |
SLE Autoantibody Specificity Hierarchy: ANA Screening vs. Anti-dsDNA, Anti-Smith, Anti-Histone & Anti-Ro/SSA
In the evaluation of Systemic Lupus Erythematosus (SLE), the Antinuclear Antibody (ANA) test (≥1:80 titer) is the mandatory entry criterion with >98% sensitivity, but low specificity (positive in Sjögren, scleroderma, autoimmune hepatitis, infections, and 5%–15% of healthy individuals). Once ANA is positive, confirmatory specificity relies on two hallmark antibodies: (1) Anti-double-stranded DNA (anti-dsDNA) (95% specific for SLE) is unique because its titers fluctuate directly with SLE disease activity and predict Lupus Nephritis (accompanied by consumption of serum C3 and C4 complement); (2) Anti-Smith (anti-Sm) (directed against snRNP core spliceosome proteins) has the highest specificity (>99%) for SLE, though its titers do not correlate with flares. Three specialized lupus antibodies appear constantly on boards: Anti-Histone antibodies are sensitive (>95%) for Drug-Induced Lupus (triggered by Hydralazine, Procainamide, Isoniazid, Minocycline, or Anti-TNF biologics, which presents with arthralgias, serositis, and fever while sparing the kidneys and CNS); Anti-Ro (SSA) and Anti-La (SSB) in a pregnant mother cross the placenta to cause Neonatal Lupus with congenital third-degree heart block; and Antiphospholipid antibodies (Lupus Anticoagulant, Anti-Cardiolipin, Anti-β2-Glycoprotein I) cause paradoxical in vitro PTT prolongation with in vivo arterial/venous thrombosis and recurrent miscarriage (plus false-positive VDRL/RPR).
Systemic Sclerosis Dichotomy (Anti-Scl-70 Diffuse vs. Anti-Centromere CREST) & Myositis Autoantibodies
Systemic Sclerosis (Scleroderma) is driven by fibroblast TGF-β activation and collagen Type I/III deposition and is divided into two mutually exclusive clinical-serologic syndromes: (1) Diffuse Cutaneous Systemic Sclerosis is associated with Anti-Scl-70 (Anti-DNA Topoisomerase I) and Anti-RNA Polymerase III antibodies; skin thickening progresses rapidly across the trunk and proximal AND distal extremities, accompanied by early visceral organ fibrosis—specifically Interstitial Lung Disease (NSIP/UIP, the #1 cause of mortality in scleroderma) and Scleroderma Renal Crisis (abrupt malignant hypertension, microangiopathic hemolytic anemia, and oliguric AKI—treated ALWAYS with ACE Inhibitors [Captopril], NEVER corticosteroids!). (2) Limited Cutaneous Systemic Sclerosis (CREST Syndrome) is associated with Anti-Centromere antibodies; skin tightening is restricted distal to the elbows/knees and face, featuring Calcinosis cutis, Raynaud phenomenon (almost always the earliest symptom), Esophageal dysmotility (smooth muscle atrophy of lower 2/3 of esophagus and LES → severe GERD), Sclerodactyly, and Telangiectasias, with late-onset isolated Pulmonary Arterial Hypertension (PAH). In inflammatory myopathies (Polymyositis/Dermatomyositis), Anti-Jo-1 (anti-histidyl-tRNA synthetase) defines Antisynthetase Syndrome (myositis + interstitial lung disease + 'mechanic's hands' + non-erosive arthritis + Raynaud), while Anti-Mi-2 correlates with classic Dermatomyositis (heliotrope rash, Gottron papules, shawl sign, and occult visceral malignancy).
Synovial Fluid Analysis & Crystal Arthropathies
Arthrocentesis is mandatory in any acute monoarthritis to distinguish crystal-induced disease from infectious septic arthritis:
| Condition | WBC Count (/ μL) | Crystal Morphology | Birefringence Under Polarized Light |
|---|---|---|---|
| Gout | 2,000 – 50,000 (> 50% PMNs) | Needle-shaped monosodium urate | Negatively birefringent (Yellow when parallel to compensator) |
| Pseudogout (CPPD) | 2,000 – 50,000 (> 50% PMNs) | Rhomboid-shaped calcium pyrophosphate | Positively birefringent (Blue when parallel to compensator) |
| Septic Arthritis | > 50,000 (often > 100,000; > 75-90% PMNs) | No crystals (unless coexisting) | Gram stain positive in 50-75% of staphylococcal infections |
Compensated Polarized Light Physics: Negative (Yellow Parallel) Gout vs. Positive (Blue Parallel) Pseudogout
Under compensated polarized light microscopy (using a red first-order compensator plate indicating the axis of slow vibration), crystal morphology and birefringence color relative to the compensator axis distinguish Gout from Pseudogout with 100% precision: (1) Acute Gouty Arthritis is caused by intra-articular precipitation of Monosodium Urate (MSU) crystals, which are needle-shaped and exhibit strong NEGATIVE birefringence—meaning they appear bright YELLOW when aligned PARALLEL to the red compensator axis and BLUE when aligned PERPENDICULAR (mnemonic: P-Y-N = Parallel Yellow Negative). Note that serum uric acid can be completely normal during an acute gout flare due to IL-1/cortisol-induced uricosuria! (2) Calcium Pyrophosphate Deposition Disease (CPPD / Pseudogout) is caused by shedding of Calcium Pyrophosphate Dihydrate crystals from hyaline and fibrocartilage (producing linear radiodense calcifications of the knee menisci or triangular fibrocartilage complex of the wrist—chondrocalcinosis); CPPD crystals are rhomboid-shaped and exhibit weakly POSITIVE birefringence (BLUE when PARALLEL and yellow when perpendicular). Whenever Pseudogout is diagnosed in a patient under age 55, screen immediately for the 4 H's of metabolic chondrocalcinosis: Hemochromatosis (also causes 2nd/3rd MCP hook osteophytes), Hyperparathyroidism, Hypomagnesemia (Gitelman), and Hypophosphatasia.
Acute Flare vs. Chronic Urate-Lowering Therapy Traps & Septic Arthritis (>50,000 WBC) Priority
Two clinical management rules are tested relentlessly in crystal arthropathy vignettes: Rule 1: Always Exclude Septic Arthritis First. Even if a patient has a known history of gout or visible intracellular MSU crystals on arthrocentesis, crystals and bacteria can coexist; a synovial fluid WBC count >50,000/μL (with >90% neutrophils) or a positive Gram stain mandates immediate hospitalized IV Vancomycin (plus Ceftriaxone if sexually active for N. gonorrhoeae or Gram-negative rods) and orthopedic surgical joint washout/drainage to prevent rapidchondrolysis. Rule 2: Acute Flare Anti-Inflammatory Therapy vs. Chronic Urate-Lowering Therapy. For an acute gout or pseudogout flare, first-line treatment is an NSAID (indomethacin/naproxen), Colchicine (binds intracellular β-tubulin to inhibit microtubule polymerization and neutrophil chemotaxis/NLRP3 inflammasome activation; causes dose-limiting diarrhea), or Intra-articular / Oral Corticosteroids (the preferred choice in patients with Chronic Kidney Disease, Peptic Ulcer Disease, or Heart Failure where NSAIDs and colchicine are contraindicated!). NEVER initiate or change the dose of Allopurinol, Febuxostat, or Probenecid during an acute gout flare—acute fluctuations in serum uric acid destabilize intra-articular tophi, prolonging and worsening the acute inflammatory attack!
Rheumatoid Arthritis vs. Osteoarthritis: Pathophysiology, Joint Distribution & Radiographic Hallmarks
Distinguishing inflammatory autoimmune synovitis from mechanical degenerative arthropathy is a foundational clinical competency. Rheumatoid Arthritis (RA) is a chronic, systemic autoimmune disease strongly linked to HLA-DR4 (shared epitope) and environmental triggers such as cigarette smoking, which promotes citrullination of self-peptides via peptidylarginine deiminase (PAD). Autoantibodies including anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF, an IgM autoantibody targeting the Fc portion of IgG) form immune complexes within the joint space. CD4+ T-helper cells (Th1 and Th17) and macrophages release TNF-alpha, IL-1, and IL-6, stimulating synovial fibroblasts to proliferate into a destructive fibrovascular granulation tissue called pannus. Osteoclast activation via RANKL erodes periarticular bone and hyaline cartilage, producing symmetric polyarthritis of the metacarpophalangeal (MCP), proximal interphalangeal (PIP), wrist, and metatarsophalangeal (MTP) joints while classically sparing the distal interphalangeal (DIP) joints. Conversely, Osteoarthritis (OA) results from age- and load-related chondrocyte senescence, matrix metalloproteinase (MMP) degradation of type II collagen and proteoglycans, and progressive loss of articular cartilage in weight-bearing joints and the DIP/PIP/1st CMC joints.
| Clinical & Diagnostic Feature | Rheumatoid Arthritis (RA) | Osteoarthritis (OA) |
|---|---|---|
| Core Pathogenesis | HLA-DR4 autoimmune synovitis; TNF-alpha/IL-1/IL-6 driven pannus erodes cartilage and bone | Mechanical wear-and-tear; MMP-mediated degradation of articular type II collagen and aggrecan |
| Morning Stiffness & Pain Pattern | Morning stiffness lasts >60 minutes; pain and swelling improve with activity and worsen with rest | Morning stiffness lasts <30 minutes; pain worsens throughout the day with weight-bearing activity |
| Characteristic Hand Distribution | Symmetric MCP, PIP, and carpal involvement; classically spares DIP joints | DIP (Heberden nodes), PIP (Bouchard nodes), and 1st carpometacarpal (CMC) base of thumb |
| Classic Deformities | Swan-neck (PIP hyperextension, DIP flexion), Boutonniere (PIP flexion, DIP hyperextension), ulnar deviation | Bony enlargement of interphalangeal joints, genu varum (bow-legged medial knee narrowing) |
| Radiographic Hallmarks | Symmetric joint space narrowing, periarticular osteopenia, marginal bone erosions, subluxations | Asymmetric joint space narrowing, subchondral sclerosis, marginal osteophytes, subchondral cysts |
| Synovial Fluid Leukocyte Count | Inflammatory: 2,000–50,000 WBC/mm³ (predominantly neutrophils during acute flares) | Non-inflammatory: <2,000 WBC/mm³ with clear, viscous, straw-colored fluid |
| First-Line & Disease-Modifying Rx | Methotrexate (first-line DMARD) + folate; bridge with low-dose corticosteroids; escalate to TNF-alpha inhibitor | Weight loss, quadriceps strengthening, topical/oral NSAIDs, acetaminophen, duloxetine, arthroplasty |
Extra-Articular Manifestations of Rheumatoid Arthritis (Felty & Caplan Syndromes)
Systemic cytokine excess and circulating immune complexes drive high-yield extra-articular complications in seropositive RA. Rheumatoid nodules (central fibrinoid necrosis surrounded by palisading epithelioid histiocytes) develop over extensor surfaces such as the olecranon and forearm as well as within the lung parenchyma. Felty syndrome consists of the classic triad of rheumatoid arthritis, splenomegaly, and neutropenia, predisposing patients to recurrent bacterial infections and leg ulcers. Caplan syndrome describes rheumatoid lung nodules coexisting with occupational pneumoconiosis (especially coal worker pneumoconiosis or silicosis). Additional extra-articular features include episcleritis, scleritis (which can perforate the sclera as scleromalacia perforans), exudative pleural or pericardial effusions with strikingly low glucose (<30 mg/dL), secondary Sjogren syndrome, carpal tunnel syndrome, and AA amyloidosis.
Atlantoaxial Subluxation & Preoperative Airway Screening
Within the cervical spine, Rheumatoid Arthritis selectively targets the synovial articulation between the anterior arch of the atlas (C1), the odontoid process (dens) of the axis (C2), and the transverse ligament of the atlas. Chronic pannus erosion of the transverse ligament allows the C1 ring to slip anteriorly relative to C2 during neck flexion, widening the anterior atlantodental interval (>3 mm in adults). Patients may present with occipital headaches, neck pain, Lhermitte sign (electric-shock sensation down the spine upon neck flexion), hyperreflexia, Babinski sign, or progressive spastic quadriparesis. Any RA patient scheduled for surgery under general anesthesia or complaining of radicular/myelopathic symptoms requires lateral flexion-extension cervical spine radiographs before endotracheal intubation; if subluxation is identified, awake fiberoptic intubation with inline cervical stabilization is mandatory.
DMARD Escalation Algorithm & Pharmacologic Toxicity Profiles
Every patient newly diagnosed with Rheumatoid Arthritis requires immediate initiation of a disease-modifying antirheumatic drug (DMARD) to halt irreversible joint destruction. Methotrexate (a dihydrofolate reductase and AICAR transformylase inhibitor that increases anti-inflammatory adenosine) is the gold-standard anchor DMARD; it is co-administered with folic acid to mitigate stomatitis, macrocytic anemia, hepatotoxicity, and myelosuppression, though teratogenicity and interstitial pneumonitis remain major risks. Leflunomide (dihydroorotate dehydrogenase inhibitor) or sulfasalazine and hydroxychloroquine serve as alternatives. If disease activity persists after 3 months, biologic DMARDs—primarily TNF-alpha inhibitors (etanercept, infliximab, adalimumab), CTLA-4-Ig costimulation blockers (abatacept), anti-IL-6 receptor antibodies (tocilizumab), or JAK inhibitors (tofacitinib)—are added.
Systemic Lupus Erythematosus (SLE): Organ Manifestations, Complement Consumption & Management
Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disorder driven by defective clearance of apoptotic cellular debris (nuclear antigens) and loss of self-tolerance in B and T lymphocytes. It predominantly affects women of childbearing age (9:1 female-to-male ratio, with higher prevalence and severity in Black, Hispanic, and Asian populations). Tissue injury occurs via both Type II hypersensitivity (direct IgG/IgM autoantibodies against erythrocytes, neutrophils, platelets, and lymphocytes causing autoimmune hemolytic anemia, leukopenia, lymphopenia, and thrombocytopenia) and Type III hypersensitivity (circulating DNA–anti-dsDNA immune complex deposition in glomerular, dermal, and serosal basement membranes). Immune complex activation of the classical complement pathway consumes serum C3 and C4; therefore, falling C3/C4 levels paired with rising anti-dsDNA titers serve as the most reliable laboratory biomarkers of an impending clinical flare, particularly lupus nephritis.
| SLE Clinical Domain / Variant | Key Pathologic & Diagnostic Features | First-Line Management & Board Pearl |
|---|---|---|
| Mucocutaneous Lupus | Malar 'butterfly' rash spares nasolabial folds; Discoid rash causes follicular plugging and scarring alopecia; painless oral ulcers | Strict photoprotection (UV light triggers keratinocyte apoptosis and systemic flares) + Hydroxychloroquine + topical steroids |
| Musculoskeletal (Jaccoud Arthropathy) | Symmetric polyarthritis of PIP/MCP/knees; non-erosive, reducible swan-neck deformities from ligamentous laxity | NSAIDs, Hydroxychloroquine, low-dose glucocorticoids; lacks the marginal bone erosions seen in Rheumatoid Arthritis |
| Lupus Nephritis (Class IV Diffuse Proliferative) | Most common and severe renal subtype; subendothelial immune complexes create 'wire-loop' capillaries on light microscopy and 'full-house' IF (IgG, IgA, IgM, C3, C1q) | Renal biopsy mandatory to classify; induction with high-dose IV methylprednisolone + Mycophenolate mofetil or Cyclophosphamide |
| Cardiovascular (Libman-Sacks Endocarditis) | Sterile, verrucous, wart-like vegetations on BOTH the ventricular and atrial surfaces of the mitral valve; associated with antiphospholipid antibodies | Treat underlying SLE and anticoagulate if thromboembolic events occur; distinguish from infective endocarditis (negative blood cultures) |
| Antiphospholipid Syndrome (APS) | Anti-cardiolipin (false-positive VDRL/RPR), anti-beta2-glycoprotein I, and Lupus Anticoagulant; unprovoked DVT/PE, stroke, or ≥3 first-trimester losses | Lifelong Warfarin (target INR 2.0–3.0) for thrombotic APS; LMW Heparin + low-dose Aspirin during pregnancy (DOACs inferior) |
| Drug-Induced Lupus (DILE) | Hydralazine, Procainamide, Isoniazid (slow acetylators), Minocycline, Anti-TNF; presents with arthralgias, myalgias, and pleuropericarditis | Anti-histone antibodies positive in >95%; anti-dsDNA and renal/CNS involvement are characteristically absent; discontinue offending drug |
Interactive 2K Master Atlas Plate
Lupus Nephritis Classification (ISN/RPS Classes I–VI)
Because clinical urinalysis findings do not reliably distinguish histological severity, renal biopsy is mandatory in any SLE patient who develops new proteinuria (>500 mg/24 hr), dysmorphic hematuria, red blood cell casts, or rising serum creatinine. Class I (minimal mesangial) and Class II (mesangial proliferative) present with microscopic hematuria and require only conservative renin-angiotensin blockade. Class III (focal proliferative, <50% of glomeruli) and Class IV (diffuse proliferative, ≥50% of glomeruli) present with nephritic sediment, hypertension, hypocomplementemia, and subendothelial deposits forming classic wire-loop lesions; both demand aggressive induction immunosuppression with high-dose corticosteroids plus mycophenolate mofetil or cyclophosphamide. Class V (membranous lupus nephritis) causes subepithelial spike-and-dome deposits and overt nephrotic-range proteinuria (>3.5 g/day), while Class VI represents advanced sclerosing end-stage renal disease (>90% global glomerulosclerosis).
Antiphospholipid Syndrome (APS) Coagulation Paradox & Obstetric Management
Antiphospholipid Syndrome occurs either as a primary disorder or secondary to SLE and requires at least one clinical criterion (vascular thrombosis or pregnancy morbidity such as unexplained fetal death after 10 weeks, premature birth before 34 weeks due to severe preeclampsia, or three consecutive spontaneous abortions before 10 weeks) plus persistent laboratory positivity on two occasions at least 12 weeks apart for lupus anticoagulant, anticardiolipin antibodies, or anti-beta2-glycoprotein I antibodies. Anticardiolipin antibodies cross-react with beef cardiolipin antigen, producing a false-positive RPR/VDRL syphilis screen. Lupus anticoagulant binds phospholipids in the in vitro aPTT reagent, prolonging the aPTT that fails to correct on a 1:1 mixing study, yet in vivo it activates endothelial cells, platelets, and complement to drive severe arterial and venous thrombosis.
Hydroxychloroquine Mandate & Retinal Toxicity Surveillance
Hydroxychloroquine is an antimalarial immunomodulator that alkalinizes endosomal/lysosomal vesicles and inhibits Toll-like receptor (TLR7 and TLR9) signaling in plasmacytoid dendritic cells. Every patient with SLE should receive baseline hydroxychloroquine regardless of disease severity because it reduces lupus flares, prevents end-organ damage, improves lipid profiles, lowers thrombotic risk, and increases overall survival. It is safe and mandatory to continue throughout pregnancy. Its signature long-term adverse effect is pigmentary retinopathy ('bull's-eye' maculopathy); patients require a baseline ophthalmologic fundoscopic exam within the first year of therapy followed by annual spectral-domain optical coherence tomography (SD-OCT) and automated visual field testing starting after 5 years of continuous use.
Systemic Sclerosis, Sjogren Syndrome & Inflammatory Myopathies
Beyond SLE and RA, board examinations heavily test the clinical and serologic differentiation of fibrosing vasculopathies, exocrine gland autoimmunity, and idiopathic inflammatory myopathies. Systemic Sclerosis (Scleroderma) is characterized by endothelial cell injury, obliterative intimal proliferation of small arteries, and excessive fibroblast activation via TGF-beta and PDGF, resulting in widespread deposition of types I and III collagen. Almost all patients present with Raynaud phenomenon (triphasic digital color change from white ischemia to blue cyanosis to red reperfusion hyperemia triggered by cold or stress) years before visceral fibrosis emerges. Sjogren Syndrome targets the lacrimal and salivary glands with a dense CD4+ lymphocytic infiltrate, producing the classic sicca complex of keratoconjunctivitis sicca and xerostomia. Dermatomyositis and Polymyositis present with symmetric proximal muscle weakness (difficulty rising from a chair, climbing stairs, or combing hair) with elevated serum creatine kinase (CK) and aldolase.
| Connective Tissue Disorder | Hallmark Autoantibodies | Pathognomonic Clinical & Histologic Features | Major Life-Threatening Complication |
|---|---|---|---|
| Diffuse Cutaneous Systemic Sclerosis | Anti-Scl-70 (Anti-topoisomerase I), Anti-RNA polymerase III | Rapid skin thickening extending proximal to elbows/knees and trunk; early visceral involvement | Interstitial Lung Disease (NSIP/UIP) and Scleroderma Renal Crisis (treat with ACE inhibitors) |
| Limited Cutaneous Scleroderma (CREST) | Anti-Centromere | Skin sclerosis restricted to fingers (sclerodactyly), distal limbs, and face; Calcinosis, Raynaud, Esophageal dysmotility, Telangiectasia | Pulmonary Arterial Hypertension (PAH — leading cause of mortality in CREST) and Primary Biliary Cholangitis |
| Mixed Connective Tissue Disease (MCTD) | Anti-U1 RNP (Ribonucleoprotein) | Overlap features of SLE, Systemic Sclerosis, and Polymyositis with prominent Raynaud phenomenon and swollen 'sausage' digits | Pulmonary arterial hypertension and interstitial lung disease |
| Sjogren Syndrome | Anti-Ro (SSA) and Anti-La (SSB) | Dry eyes (positive Schirmer test, rose bengal staining), dry mouth, bilateral parotid enlargement, focal lymphocytic sialadenitis on lip biopsy | Extranodal Marginal Zone B-cell (MALT) Lymphoma of the parotid gland; Neonatal Complete Heart Block in offspring |
| Dermatomyositis | Anti-Mi-2 (classic rash), Anti-Jo-1 (antisynthetase syndrome: ILD, mechanic's hands) | Heliotrope violaceous eyelid rash, Gottron papules over PIP/MCP knuckles, shawl sign; perimysial CD4+ inflammation and perifascicular atrophy | Underlying occult visceral adenocarcinoma (ovarian, lung, GI, breast); interstitial lung disease |
| Polymyositis | Anti-Jo-1 (histidyl-tRNA synthetase), Anti-SRP | Symmetric proximal muscle weakness without cutaneous involvement; endomysial CD8+ T-cell infiltration directly invading MHC-I expressing myofibers | Respiratory muscle weakness, dysphagia/aspiration pneumonia, and fibrosing alveolitis |
Diffuse vs. Limited (CREST) Scleroderma & Scleroderma Renal Crisis
Systemic sclerosis is stratified by the extent of cutaneous involvement and autoantibody specificity. Limited cutaneous systemic sclerosis (CREST syndrome) spares the trunk and proximal limbs, progresses slowly, is strongly associated with anti-centromere antibodies, and carries a high late risk of pulmonary arterial hypertension (PAH) (smooth muscle proliferation in pulmonary arterioles causing progressive exertional dyspnea and loud P2). Diffuse cutaneous systemic sclerosis is associated with anti-Scl-70 (anti-topoisomerase I) and anti-RNA polymerase III antibodies, involves the trunk and proximal extremities early, and rapidly causes interstitial lung disease (ILD)—now the leading overall cause of death in scleroderma. Patients with anti-RNA polymerase III antibodies or those exposed to systemic glucocorticoids are at high risk for Scleroderma Renal Crisis, an oliguric renal emergency presenting with abrupt malignant hypertension, retinopathy, thrombocytopenia, and schistocytes on peripheral smear; immediate administration of an ACE inhibitor (captopril) is life-saving.
Sjogren Syndrome, Neonatal Lupus & Parotid Lymphoma
In Primary Sjogren Syndrome, autoimmune destruction of exocrine acinar epithelium produces severe xerophthalmia (gritty, burning eyes confirmed by a Schirmer tear test <5 mm in 5 minutes) and xerostomia (severe dental caries, oral candidiasis, and difficulty swallowing dry cracker food). Definitive diagnosis relies on serologic detection of anti-Ro (SSA) and anti-La (SSB) autoantibodies or a minor salivary gland (lower lip) biopsy showing focal lymphocytic sialadenitis. Two board-critical complications must be monitored: first, transplacental passage of maternal IgG anti-Ro/SSA and anti-La/SSB antibodies during pregnancy attacks the fetal atrioventricular node, causing irreversible congenital complete (3rd-degree) heart block and neonatal periorbital lupus rash; second, chronic B-cell stimulation confers a 15- to 40-fold increased risk of parotid gland MALT lymphoma, which presents as a firm, rapidly enlarging, unilateral parotid mass accompanied by falling serum complement (C4) and cryoglobulinemia.
Dermatomyositis vs. Polymyositis vs. Inclusion Body Myositis
While both Dermatomyositis (DM) and Polymyositis (PM) present with subacute, painless, symmetric proximal muscle weakness and elevated serum CK, their immunopathology and dermatologic profiles are distinct. Dermatomyositis is a humorally mediated microangiopathy featuring complement (C5b-9 membrane attack complex) deposition in endomysial capillaries, perimysial CD4+ T-cell and B-cell inflammation, and pathognomonic perifascicular myofiber atrophy. Its cutaneous hallmarks include Gottron papules (scaly violaceous plaques over the dorsal MCP/PIP joints), the heliotrope rash (violaceous periorbital edema), and the photosensitive shawl and V-neck signs. Polymyositis lacks skin findings and is driven by endomysial CD8+ cytotoxic T cells that surround and destroy individual myofibers via perforin and granzyme. In contrast, Inclusion Body Myositis (IBM) affects older men (>50 years), causes asymmetric weakness of both proximal (quadriceps) and distal muscles (finger flexors and ankle dorsiflexors), shows rimmed vacuoles with beta-amyloid deposits on biopsy, and is characteristically refractory to corticosteroid therapy.
Acute vs. Chronic Gout, Pseudogout (CPPD) & Septic Arthritis Management
When a patient presents with an acute, erythematous, warm, swollen monoarthritis (such as the first metatarsophalangeal joint in podagra or the knee), the clinician must rapidly distinguish crystalline synovitis from bacterial joint destruction. Arthrocentesis with synovial fluid analysis (cell count with differential, Gram stain, bacterial culture, and compensated polarized light microscopy) is the definitive gold standard and must be performed before starting empiric antibiotics or intra-articular steroids. Importantly, the presence of intracellular crystals on microscopy does not exclude coexisting septic arthritis, as bacterial infection can strip cartilage matrix and release preformed crystals into the synovial space.
| Parameter | Gout (Monosodium Urate) | Pseudogout (CPPD) | Septic Arthritis |
|---|---|---|---|
| Crystal Composition & Shape | Monosodium urate (MSU); sharp, intracellular and extracellular needle-shaped crystals | Calcium pyrophosphate dihydrate (CPPD); blunt, rhomboid-shaped or rod-like crystals | No crystals (though coexisting crystals do not rule out bacterial infection) |
| Polarized Light Birefringence | Strongly negatively birefringent: Yellow when parallel to the red compensator axis, Blue when perpendicular | Weakly positively birefringent: Blue when parallel to the red compensator axis, Yellow when perpendicular | Negative crystal exam; positive Gram stain in 50–70% of non-gonococcal cases |
| Classic Anatomic Site | 1st MTP joint (podagra), midfoot/instep, ankle, knee, olecranon bursa; chronic chalky tophi on ear helix/Achilles | Knee (>50% of cases), wrist (triangular fibrocartilage complex), MCP joints (especially 2nd and 3rd MCPs in hemochromatosis) | Knee (most common native joint), hip, shoulder, ankle; sacroiliac/sternoclavicular joints in IV drug users |
| Radiographic Appearance | Punched-out periarticular erosions with overhanging cortical edges ('rat-bite' erosions) and preserved joint space until late | Chondrocalcinosis (linear calcific stippling within hyaline cartilage and fibrocartilage menisci) | Acute soft-tissue swelling and joint effusion; rapid symmetric joint space loss and subchondral destruction within days if untreated |
| Predisposing Risk Factors | Thiazide/loop diuretics, alcohol (beer), red meat/seafood, CKD, tumor lysis syndrome, Lesch-Nyhan syndrome (HGPRT deficiency) | Aging, osteoarthritis, Hereditary Hemochromatosis, Hyperparathyroidism, Hypomagnesemia (Gitelman syndrome), Hypothyroidism | Staphylococcus aureus (prosthetic joints, RA, skin ulcers); Neisseria gonorrhoeae (sexually active young adults: tenosynovitis, dermatitis, polyarthralgia) |
| Synovial Fluid WBC Count | 2,000–50,000 WBC/mm³ (occasionally >50,000 in severe acute flares; >50% PMNs) | 2,000–50,000 WBC/mm³ (inflammatory neutrophil predominance) | >50,000 WBC/mm³ (often >100,000 WBC/mm³ with >90% polymorphonuclear neutrophils) |
| Definitive Management | Acute: NSAIDs (indomethacin), colchicine, or steroids. Chronic: Allopurinol, febuxostat, or pegloticase | Acute: Intra-articular corticosteroid injection, oral NSAIDs, or low-dose colchicine (no urate-lowering therapy exists) | Emergent surgical drainage/serial needle aspiration + empiric IV Vancomycin (add Ceftriaxone if Gram-negative rods or gonococcus suspected) |
Acute Gout Flare Pharmacology vs. Chronic Urate-Lowering Therapy
Management of gout is strictly divided into terminating acute neutrophil-mediated synovitis versus long-term prevention of hyperuricemia (serum uric acid target <6.0 mg/dL). For an acute gout flare, first-line options depend on renal and gastrointestinal comorbidities: oral NSAIDs (indomethacin or naproxen) are preferred in patients with normal renal function and no peptic ulcer disease; colchicine (binds beta-tubulin to inhibit microtubule polymerization and neutrophil chemotaxis/NLRP3 inflammasome activation; causes dose-limiting diarrhea and neuromyopathy) is effective if started within 36 hours; and intra-articular or oral glucocorticoids (prednisone) are the safest choice in patients with stage 3–5 chronic kidney disease or active peptic ulcers. Chronic urate-lowering therapy is indicated for patients with ≥2 flares per year, tophi, urate nephrolithiasis, or chronic kidney disease. First-line chronic therapy uses xanthine oxidase inhibitors (allopurinol or febuxostat); note that allopurinol requires HLA-B*5801 screening in high-risk Asian populations (Stevens-Johnson syndrome risk) and demands a 75% dose reduction of concurrent azathioprine or 6-mercaptopurine (which are metabolized by xanthine oxidase). Pegloticase (recombinant uricase that converts uric acid to water-soluble allantoin) is reserved for refractory tophaceous gout.
Secondary Causes of CPPD (Pseudogout): The 4 H's
Whenever a patient under age 55 presents with acute calcium pyrophosphate dihydrate (CPPD) crystal deposition disease or radiographic chondrocalcinosis (particularly involving the 2nd and 3rd MCP joints alongside the knee or wrist), boards test the underlying metabolic triggers known as the 4 H's: Hereditary Hemochromatosis (iron overload inhibits inorganic pyrophosphatase; screen with transferrin saturation >45% and ferritin), Hyperparathyroidism (elevated PTH and hypercalcemia promote crystal shedding), Hypomagnesemia (magnesium is a required cofactor for alkaline phosphatase/pyrophosphatase; associated with Gitelman and Bartter syndromes), and Hypothyroidism.
Non-Gonococcal vs. Disseminated Gonococcal Septic Arthritis
Bacterial invasion of the synovial space (which lacks a limiting basement membrane) causes rapid chondrolysis within 24 to 48 hours via bacterial toxins and host neutrophil proteases. Non-gonococcal septic arthritis is caused most frequently by Staphylococcus aureus (including MRSA), followed by Streptococcus species and Pseudomonas aeruginosa (in intravenous drug users or nail-puncture wounds through rubber-soled sneakers). It presents as a monoarticular surgical emergency requiring serial arthrocentesis or arthroscopic washout plus empiric IV vancomycin (plus cefepime or ceftriaxone if Gram-negative bacilli are seen). Conversely, Disseminated Gonococcal Infection (DGI) in young, sexually active patients presents either as a purulent monoarthritis or as the classic triad of migratory polyarthralgia, tenosynovitis (wrist/ankle tendons), and sparse acral pustular/vesicular dermatitis; because synovial fluid cultures are frequently negative in DGI, nucleic acid amplification testing (NAAT) of urogenital, pharyngeal, and rectal mucosa should be obtained alongside blood cultures, and treatment consists of IV ceftriaxone.
COMLEX / OMM Integration
NBOME High-Yield Correlate
Osteopathic Considerations in Systemic Rheumatic & Articular Disease
Osteopathic management of patients with systemic autoimmune and crystalline arthropathies integrates autonomic balancing, lymphatic drainage, and strict biomechanical safety. Sympathetic innervation to the upper extremities originates from T2–T8 (synapsing in the stellate and middle cervical ganglia), whereas lower extremity vascular tone is governed by T11–L2; viscerosomatic facilitation at these segments increases periarticular vasoconstriction, impairs synovial clearance of inflammatory cytokines, and amplifies nociceptive sensitization. Parasympathetic regulation of systemic cardiopulmonary and gastrointestinal viscera affected by connective tissue diseases travels via the vagus nerve (CN X) (anterior and posterior Chapman reflexes at the 2nd–5th intercostal spaces and T2–T5 transverse processes), while pelvic organs receive sacral parasympathetic outflow from S2–S4. Key Counterstrain tenderpoints in rheumatic flares include the supraspinatus, infraspinatus, lateral epicondyle (radial head), medial and lateral meniscus, and piriformis points, which are shortened and folded for 90 seconds before passive return to neutral. During acute synovitis (gout, septic arthritis, or acute RA flare), direct techniques over inflamed joints and all High-Velocity Low-Amplitude (HVLA) thrusts are contraindicated. Cervical HVLA is an absolute contraindication in Rheumatoid Arthritis due to pannus-mediated destruction of the transverse ligament of the atlas (C1–C2 atlantoaxial instability). Safe adjunctive modalities include thoracic inlet myofascial release, doming of the thoracoabdominal diaphragm, pedal/thoracic lymphatic pump, and indirect myofascial release or balanced ligamentous tension (BLT) to reduce joint effusion and edema.
Board Traps & Common Distractors
- Before performing endotracheal intubation or cervical HVLA in any patient with longstanding Rheumatoid Arthritis, ALWAYS obtain lateral flexion-extension cervical spine radiographs to rule out C1-C2 atlantoaxial subluxation (transverse ligament destruction by pannus); neck hyperextension can transect the spinal cord.
- Never initiate or adjust allopurinol or febuxostat during an acute gout flare; sudden fluctuations in serum uric acid mobilize tissue urate stores, destabilize intra-articular microtophi, and severely prolong acute synovitis.
- In Systemic Sclerosis (Scleroderma), avoid high-dose systemic corticosteroids whenever possible because they precipitate Scleroderma Renal Crisis (malignant hypertension and microangiopathic hemolytic anemia); treat renal crisis immediately with ACE inhibitors (captopril) even if serum creatinine is rising.
- Antiphospholipid Syndrome (APS) paradoxically prolongs the in vitro aPTT (due to lupus anticoagulant interfering with phospholipid-dependent coagulation assays) despite causing a prothrombotic state in vivo (recurrent venous/arterial thrombosis and recurrent pregnancy loss).
- Every patient diagnosed with adult-onset Dermatomyositis requires age-appropriate and targeted malignancy screening (CT chest/abdomen/pelvis, colonoscopy, mammography, pelvic ultrasound) because up to 25% harbor an underlying occult adenocarcinoma (ovarian, lung, gastric, pancreatic, or colorectal).
- Before starting biological DMARDs (infliximab, adalimumab, etanercept) for Rheumatoid Arthritis, patients must be screened for latent Mycobacterium tuberculosis (IGRA or PPD plus chest radiograph) and chronic Hepatitis B virus, as TNF-alpha inhibition causes fatal granuloma breakdown and viral reactivation.
- A prosthetic or native joint presenting with acute monoarticular erythema, swelling, and fever is septic arthritis until proven otherwise; never inject intra-articular corticosteroids before synovial fluid Gram stain, culture, and leukocyte count exclude bacterial infection.
Previous Chapter
•
Vol 2: Clinical Ch. 18
Seizure Classification, Status Epilepticus & Neuromuscular Disorders
Vol 2: Clinical Ch. 20
•
Next Chapter
Pediatric Exanthems, Congenital Defects & Neonatal Jaundice
Table of Contents (105 Chapters)
Volume 2: Organ System Clinical Pathology • Chapter 19 of 60